Clinical Trial Update: Study of Chemotherapy Combined With Nimotuzumab in Untreated Metastatic Nasopharyngeal Carcinoma [Phase 2]

View source ↗

Summary

This update reports the completion of a Phase 2 study evaluating chemotherapy in combination with Nimotuzumab for untreated metastatic nasopharyngeal carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Carcinoma

Drugs mentioned

• Nimotuzumab (nimotuzumab)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Stage IV Nasopharyngeal Carcinoma | Phase 2 | Status: COMPLETED